COX-2 selective inhibitors - they are still the best treatment for many patients!

COX-2 selective inhibitors - they are still the best treatment for many patients!

Bibliographic Details
Main Author:	K Brune
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2005-03-01
Series:	Swiss Medical Weekly
Subjects:	COX2 inhibitor
Online Access:	https://www.smw.ch/index.php/smw/article/view/476

Similar Items

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
by: U Klotz
Published: (2005-03-01)

The Effect of Selectivity of Inhibitors to Cox-2 Enzyme on Hepatobiliary and Platelet Function in Patients with Osteoarthritis
by: Ali M. Hadi, et al.
Published: (2010-01-01)

Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
by: Pedro H. F. Araújo, et al.
Published: (2020-09-01)

COX-2 as a potential biomarker and therapeutic target in melanoma
by: Diana Valentina Tudor, et al.
Published: (2020-02-01)

Evidence of use: A selective COX-2 inhibitor in the treatment of experimental chronic pancreatitis induced by Dibutyltin dichloride
by: Sukhodolya Sergij, et al.
Published: (2015-06-01)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01)

Quantitative structure–activity relationship based modeling of substituted indole Schiff bases as inhibitor of COX-2
by: Amrita Dwivedi, et al.
Published: (2016-09-01)

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
by: Afaf A. El-Malah, et al.
Published: (2022-07-01)

Chondroprotective Actions of Selective COX-2 Inhibitors In Vivo: A Systematic Review
by: Ufuk Tan Timur, et al.
Published: (2020-09-01)

Efficacy of radiation treatment in combination with COX-2 inhibitor in patients with NSCLC
by: Н. В. Білозор, et al.
Published: (2020-11-01)

Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors
by: Deema A. Al-Turki, et al.
Published: (2017-01-01)

Multifocal fixed drug eruption with COX-2 inhibitor-celecoxib
by: Shikha Chugh, et al.
Published: (2013-01-01)

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
by: Zhiran Ju, et al.
Published: (2022-06-01)

Pharmacokinetics, Tissue Distribution, Metabolism and Excretion of a Novel COX-2 Inhibitor, Vitacoxib, in Rats
by: Jianzhong Wang, et al.
Published: (2022-04-01)

The COX-2 inhibitors: a reasoned review of the data
by: L Simon
Published: (2005-07-01)

A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets
by: Qianghua Hu, et al.
Published: (2017-01-01)

Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma
by: M Tinguely, et al.
Published: (2006-07-01)

The Investigation of the Cox-2 Selective Inhibitor Parecoxib Effects in Spinal Cord Injury in Rat
by: Ulas Yuksel, et al.
Published: (2019-07-01)

Pharmacodynamic and Pharmacokinetic Comparison between Selective and Non-selective COX-2 Inhibitors in Mice
by: Taimaa Yahya, et al.
Published: (2024-04-01)

Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion
by: T Kistler, et al.
Published: (2001-04-01)

Molecular docking of taraxerol acetate as a new COX inhibitor
by: Ubaid Ur Rehman, et al.
Published: (2013-05-01)

Selective COX-2 inhibitors do not increase gastrointestinal reactions after colorectal cancer surgery: a systematic review and meta-analysis
by: Ting Hu, et al.
Published: (2023-08-01)

Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
by: Francesca Lombardi, et al.
Published: (2022-01-01)

Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
by: Alessandra Pannunzio, et al.
Published: (2018-10-01)

COX-2 in Cancer: Gordian knot or Achilles heel?
by: Ioannis eStasinopoulos, et al.
Published: (2013-03-01)

Synthesis, molecular modeling, anti-cancer and COX-1/2 inhibitory activities of novel thiazolidinones containing benzothiazole core
by: Necla Kulabas, et al.
Published: (2024-03-01)

Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
by: Ping Zhou, et al.
Published: (2017-09-01)

Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain
by: Jie Wen, et al.
Published: (2023-04-01)

Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury
by: Melissa Jones, et al.
Published: (2018-12-01)

Effect of COX-2 Inhibitors Selectivity on Lipid Profile in Hyperlipidemic and Normolipidemic Type 2 Diabetics
by: Najwan K. Fakree, et al.
Published: (2017-03-01)

The efficacy and safety of selective COX-2 inhibitors for postoperative pain management in patients after total knee/hip arthroplasty: a meta-analysis
by: Mingyang Jiang, et al.
Published: (2020-02-01)

Synthesis, Anti-Inflammatory and Anti- Nociceptive Activities and Cytotoxic Effect of Novel Thiazolidin-4-ones Derivatives as Selective Cyclooxygenase (COX-2) Inhibitors
by: Seyed Adel Moallem, et al.
Published: (2013-12-01)

Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs
by: Nada H. El-Dershaby, et al.
Published: (2022-09-01)

COMPUTATION DESIGN OF QUINAZOLINE-4(3H)-ON DERIVATIVES AS CYCLOOXYGENASE-2 (COX-2) INHIBITOR
by: Anita Puspa Widiyana
Published: (2021-11-01)

In vitro Assessment of Anti-Inflammatory and COX-2 inhibitory action of some medicinal plants
by: Usama Ramadhan
Published: (2020-08-01)

Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme
by: Nada H. El-Dershaby, et al.
Published: (2022-12-01)

<i>m</i>-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity
by: Damiano Rocchi, et al.
Published: (2023-07-01)

Identification of N-Acetyldopamine Dimers from the Dung Beetle Catharsius molossus and Their COX-1 and COX-2 Inhibitory Activities
by: Juan Lu, et al.
Published: (2015-08-01)

Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
by: Geoffrey Mark Verrall, et al.
Published: (2020-09-01)

COX ARCHITECTS : Selected and Current Works /
by: Dobney, Stephen, editor 208043, et al.
Published: (1994)